DLG1 and Parkinson disease: In the CA3 region, SAP97 was increased 2.22 ± 0.51 fold in HD (n = 5; P < 0.05) and 1.62 ± 0.26 fold in PD (n = 10; P < 0.05) above control (n = 6).